Vuno Inc. (KOSDAQ:338220)

-23.89% (1Y)

Market Cap	268.13B
Revenue (ttm)	27.87B
Net Income (ttm)	-12.41B
Shares Out	14.00M
EPS (ttm)	-894.66
PE Ratio	n/a
Forward PE	190.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,974
Average Volume	82,286
Open	19,300
Previous Close	19,150
Day's Range	19,020 - 19,980
52-Week Range	15,490 - 39,700
Beta	1.45
RSI	56.24
Earnings Date	Aug 13, 2025

About Vuno Inc.

Vuno Inc. operates as a medical artificial intelligence (AI) solution development company. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. Its products include BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalit...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 338220

Financial Performance

In 2024, Vuno Inc.'s revenue was 25.87 billion, an increase of 94.86% compared to the previous year's 13.28 billion. Losses were -13.02 billion, -16.69% less than in 2023.